Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Melasma Pathogenesis and Epidemiology: A Complex Tempest of Photodamage

Description

The speaker describes melasma as a “tempest” because of both its emotional impact on patients and its biologic complexity. Using the metaphor of a chaotic-looking but highly structured building and an orchestra, the talk explains that melasma arises from a coordinated interaction of multiple cells and signals in the skin. Epidemiologically, it affects about 1% of the population overall, is more common with high UVA exposure, usually presents as malar or central facial pigmentation, and often begins in the 30s; family history is common and lighter skin types may develop it earlier. The pathogenesis is presented as a multifactorial process involving genetics, UV/visible/infrared light, hormonal influences, oxidative stress, subclinical inflammation, basement membrane damage, solar elastosis, increased vascularity, mast cell activity, fibroblast senescence, endothelial signaling, and possibly sebocytes. Histologically, melasma shows increased melanin, hypertrophic melanocytes, disrupted basement membrane, dermal changes, and pigmentary gene alterations. The key conclusion is that melasma is a complex phenotype of photodamage that requires multimodal treatment rather than a single therapy.

View more

Conclusions

Melasma appears to be a highly complex, multifactorial disorder rather than a simple pigment problem, with coordinated interactions among epidermal, dermal, vascular, inflammatory, and hormonal pathways.
The condition imposes a substantial psychosocial burden, including reduced quality of life, stigma, shame, anxiety, and a high prevalence of depression.
Melasma is best understood as a phenotype of photodamage driven by genetics plus ultraviolet, visible, and infrared light exposure, especially in predisposed individuals.
Although the surface looks chaotic, the underlying biology is synchronous and organized, involving multiple skin cell types that communicate to sustain hyperpigmentation.
Oxidative stress and subclinical inflammation likely contribute meaningfully to disease activity, supporting the need for antioxidant and anti-inflammatory approaches.
Basement membrane disruption and solar elastosis are central pathological features and may help explain pendulous melanocytes and dermal pigment changes.
Dermal vascular changes and endothelial signaling are important contributors, suggesting that angiogenesis is part of melasma pathogenesis.
Mast cells and fibroblasts appear to be major players in the dermal microenvironment, promoting pigment production, matrix damage, and disease persistence.
Sebocytes and hormonal influences may also participate, but hormonal mechanisms remain incompletely understood and more complex than previously thought.
Because melasma arises from multiple interacting pathways, effective treatment likely requires a combination strategy rather than a single intervention.

Zhu Y et al. PLoS ONE 2022.
Chen W et al. Frontiers in Psychiatry 2024.
Ribeirio MM et al. Pharmaceutics 2025.
Dreno B et al. World Congress of Derm 2023.
Rahimi H et al. J Cosmet Dermatol 2024;23:284-286.
Kang HY et al. JID. 2011;131(8):1692-700.
Kim EH et al. J Dermatol Science. 2007;46:111-116.
Torres-Álvarez B et al. Am J Dermatopath. 2011;33(3):291-5.
Espósito et al. Arch Dermatol Res. 2020;312:223–227.
Kim M et al. Experimental Dermatol. 2019;28(6):719-22.
Flori et al. iScience 2022.